Skip to main content
Top
Literature
1.
go back to reference Patocs A, Lendvai NK, Butz H, Liko I, Sapi Z, Szucs N et al (2016) Novel SDHB and TMEM127 mutations in patients with pheochromocytoma/Paraganglioma syndrome. Pathol Oncol Res 22(4):673–679 Patocs A, Lendvai NK, Butz H, Liko I, Sapi Z, Szucs N et al (2016) Novel SDHB and TMEM127 mutations in patients with pheochromocytoma/Paraganglioma syndrome. Pathol Oncol Res 22(4):673–679
2.
go back to reference Kolackov K, Tupikowski K, Bednarek-Tupikowska G (2012) Genetic aspects of pheochromocytoma. Adv Clin Exp Med 21(6):821–829official organ Wroclaw Medical UniversityPubMed Kolackov K, Tupikowski K, Bednarek-Tupikowska G (2012) Genetic aspects of pheochromocytoma. Adv Clin Exp Med 21(6):821–829official organ Wroclaw Medical UniversityPubMed
3.
go back to reference Jochmanova I, Zhuang Z, Pacak K (2015) Pheochromocytoma: gasping for air. Horm Cancer 6(5–6):191–205CrossRefPubMed Jochmanova I, Zhuang Z, Pacak K (2015) Pheochromocytoma: gasping for air. Horm Cancer 6(5–6):191–205CrossRefPubMed
4.
go back to reference Santos P, Pimenta T, Taveira-Gomes A (2014) Hereditary Pheochromocytoma. Int J Surg Pathol 22(5):393–400CrossRefPubMed Santos P, Pimenta T, Taveira-Gomes A (2014) Hereditary Pheochromocytoma. Int J Surg Pathol 22(5):393–400CrossRefPubMed
Metadata
Title
Genetic Screening in Pheochromocytoma/Paraganglioma
Authors
Peihua Liu
Xiongbing Zu
Longfei Liu
Publication date
01-01-2017
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 1/2017
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-016-0117-y

Other articles of this Issue 1/2017

Pathology & Oncology Research 1/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine